Treatment in laryngeal papillomatosis


The juvenile laryngeal papillomatosis is the treatment in laryngeal papillomatosis frequent benign tumour of the larynx. In Sir Morrel MacKenzie describes papillomas as pharyngo-laryngeal detoxifiere colon secom at a child, and the term of juvenile laryngeal papillomatosis has treatment in laryngeal papillomatosis introduced by Chevalier Jakson in The etiological agent is HPV types 6 and 11 and the treatment in laryngeal papillomatosis of the respiratory tract the most frequently infected is the squamocolumelar junction.

cancer endometrial metastaze

Juvenile laryngeal papillomatosis is a disease more frequent between 3 and 5 years, characterised by multiple relapses and exuberant growth at the level of the laryngeal mucosa. The annual costs of the treatment of this disease are over million USD. The evolution of the disease decreases the quality of the life of the patient and malignancy and death can occur during the disease.

treatment in laryngeal papillomatosis hashtag rezist parazitii

Objectives: bringing new informations about the etiology, the diagnosis and the treatment of the disease for the specialties that deal with this pathology, especially paediatrics and otolaryngologists. The treatment in laryngeal papillomatosis of the patients with laryngeal papillomatosis depends on the early treatment in laryngeal papillomatosis and the corresponding treatment.

treatment in laryngeal papillomatosis

Material and method: using data from the literature of specialty and the clinical experience in the ENT Clinic in Timisoara we present actualities in treatment in laryngeal papillomatosis epidemiology, the diagnosis and the treatment in the juvenile laryngeal papillomatosis.

Conclusions: juvenile laryngeal papillomatosis is caused by the HPV types 6 and The treatment follows two objectives: relapses and the reestablishment of the respiratory and phonatory function.

treatment in laryngeal papillomatosis